FilingSEC EDGAR8-K
Perspective Therapeutics Enters Clinical Collaboration and Supply Agreement with Merck
· SEC accepted
StagePhase 1/2a
Filing content
Perspective Therapeutics entered into a clinical collaboration agreement with Merck to evaluate [212Pb]PSV359 in combination with Keytruda in patients with solid tumors.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…